Open Access

Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis

  • Authors:
    • Zhifang Zhao
    • Lijiang Tao
    • Chengchun Shen
    • Bing Liu
    • Zhengming Yang
    • Huimin Tao
  • View Affiliations

  • Published online on: December 9, 2013     https://doi.org/10.3892/ijmm.2013.1578
  • Pages: 271-276
  • Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Although surgical excision following neoadjuvant chemotherapy has contributed to the long-term survival of osteosarcoma patients, patients that do not respond to commonly used drugs including cisplatin, have a poor prognosis. Autophagy is important in the inhibition of chemotherapeutic apoptosis. Therefore, we investigated whether knockdown of Beclin1-associated autophagy-related key regulator (Barkor/ATG14) promoted cisplatin-induced apoptosis in a drug-resistant osteosarcoma cell line in vitro. Saos-2 cells were transfected with Barkor siRNA. Sensitivity of the Barkor siRNA-transfected cell line to cisplatin was evaluated. Silencing of Barkor did not directly inhibit the growth rate of the transfected cells, but it significantly increased their sensitivity to cisplatin. The results of flow cytometry and 4',6-diamidino-2-phenylindole (DAPI) staining revealed that Barkor siRNA-transfected Saos-2 cells treated with cisplatin exhibited much higher rates of apoptosis than the control and control siRNA-transfected cells. Additionally, the combination of silencing of Barkor with cisplatin treatment promoted the expression of caspase-12 and calpain. The increase of cisplatin cytotoxicity may therefore be involved in endoplasmic reticulum (ER) stress-associated apoptosis. Bcl-2 was markedly downregulated in dose‑dependent cisplatin‑treated Barkor-transfected-Saos-2 cells. Findings of the present study suggest that the combination of silencing of Barkor and cisplatin enhanced the antitumor efficacy through the Barkor‑related ER- and mitochondrial-mediated apoptotic pathway.
View Figures
View References

Related Articles

Journal Cover

2014-February
Volume 33 Issue 2

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao Z, Tao L, Shen C, Liu B, Yang Z and Tao H: Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis. Int J Mol Med 33: 271-276, 2014.
APA
Zhao, Z., Tao, L., Shen, C., Liu, B., Yang, Z., & Tao, H. (2014). Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis. International Journal of Molecular Medicine, 33, 271-276. https://doi.org/10.3892/ijmm.2013.1578
MLA
Zhao, Z., Tao, L., Shen, C., Liu, B., Yang, Z., Tao, H."Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis". International Journal of Molecular Medicine 33.2 (2014): 271-276.
Chicago
Zhao, Z., Tao, L., Shen, C., Liu, B., Yang, Z., Tao, H."Silencing of Barkor/ATG14 sensitizes osteosarcoma cells to cisplatin‑induced apoptosis". International Journal of Molecular Medicine 33, no. 2 (2014): 271-276. https://doi.org/10.3892/ijmm.2013.1578